DJIA 17,577.23 220.36 1.27%
NASDAQ 4,709.38 65.07 1.40%
S&P 500 2,041.16 28.27 1.40%
market minute promo

187.97 5.89 (3.23%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALXN $188.16 3.34%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $185.89
Previous Close $182.08
Daily Range $184.00 - $188.00
52-Week Range $122.69 - $203.30
Market Cap $37.3B
P/E Ratio 75.87
Dividend (Yield) $0.00 (0.0%)
Volume 593,330
Average Daily Volume 980,691
Current FY EPS $4.72

Sector

Healthcare

Industry

Drugs

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website: http://www.alexionpharm.com/

News & Commentary Rss Feed

3 Companies Growing Faster Than MannKind Corporation

MannKind may be on the precipice of growth surge thanks to Afrezza, but these three biotech stocks are still growing faster than MannKind.

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results -

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog

Insider Trading Alert - DXCM, ALXN And FRGI Traded By Insiders

Alexion Announces New Share Repurchase Program of $500M - Analyst Blog

Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog

The New #47 Most Shorted Nasdaq 100 Component: Alexion Pharmaceuticals

ChemoCentryx: Can It Break Into The Soliris Market?

Are Investors Signaling Optimism in Biotechs Through Short Interest?

Insider Trading Alert - PNW, BCEI And ALXN Traded By Insiders

Weekly CFO Sells Highlight: Alexion Pharmaceuticals Inc, Equity Residential, Tableau Software Inc.

See More ALXN News...

ALXN's Top Competitors

ALXN $187.97 (3.23%)
Current stock: ALXN
AMGN $167.00 (2.15%)
Current stock: AMGN
GILD $104.99 (2.53%)
Current stock: GILD
BIIB $344.58 (3.51%)
Current stock: BIIB